• Thumbnail for Soberana 02
    Soberana 02 or Soberana 2, technical name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute...
    40 KB (3,671 words) - 14:05, 24 January 2024
  • Pakistan Uzbekistan Travel-only Hong Kong Malaysia New Zealand Turkey Soberana 02, is a conjugate vaccine developed by the Finlay Institute in Cuba. Full...
    318 KB (19,351 words) - 20:00, 21 April 2024
  • Thumbnail for Soberana Plus
    for Soberana 02. On 20 August 2021, Cuba approved Soberana Plus as a booster after two doses of Soberana 02. On 23 September, Cuba approved Soberana Plus...
    7 KB (575 words) - 13:21, 24 January 2024
  • FINLAY-FR-2, COVID-19 vaccine candidate, also known as SOBERANA-02, which followed the earlier SOBERANA-01, produced by the Finlay Institute, a Cuban epidemiological...
    371 bytes (76 words) - 19:57, 18 July 2021
  • Thumbnail for Conjugate vaccine
    typhoid fever in many children under the age of five years. In 2021, Soberana 02, a conjugate COVID-19 vaccine developed in Cuba, was given emergency...
    10 KB (1,108 words) - 08:35, 6 December 2023
  • EpiVacCorona, ZF2001, MVC-COV1901, Corbevax, the Sanofi–GSK vaccine, and Soberana 02 (a conjugate vaccine). Bimervax was approved for use as a booster vaccine...
    192 KB (22,024 words) - 10:32, 9 May 2024
  • During the COVID-19 pandemic, Cuba developed two COVID-19 vaccines. Soberana 02 is produced by the Pasteur Institute of Iran and the Finlay Institute...
    78 KB (9,169 words) - 12:41, 25 April 2024
  • Thumbnail for 2021 Cuban protests
    decided not to buy vaccines from overseas and instead, developed its own: Soberana 02 and Abdala. The Miami Herald and The Wall Street Journal described the...
    173 KB (17,110 words) - 03:00, 29 March 2024
  • response to fight against COVID-19, Finlay Institute has developed the Soberana 02. In March 2021, Vicente Vérez, director of the Finlay Institute, announced...
    3 KB (187 words) - 16:06, 11 December 2023
  • Thumbnail for COVID-19 vaccine clinical research
    Novavax, Razi Cov Pars, Sanofi–GSK, Sinopharm CNBG, Skycovione, Soberana 02, Soberana Plus, V-01, and ZF2001. one virus-like particle vaccine: CoVLP As...
    98 KB (20,593 words) - 02:58, 8 March 2024